Azaindole derivatives and their use as ERK kinase inhibitors

The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Labesse, Gilles, Mathieu, Loic, Bories, Cédric, Guichou, Jean-François, Gelin, Muriel, Geoffroy, Clément, Bessin, Yannick, Duquenne, Charline
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Labesse, Gilles
Mathieu, Loic
Bories, Cédric
Guichou, Jean-François
Gelin, Muriel
Geoffroy, Clément
Bessin, Yannick
Duquenne, Charline
description The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11708364B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11708364B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11708364B23</originalsourceid><addsrcrecordid>eNrjZLBxrErMzEvJz0lVSEktyixLLMksSy1WSMxLUSjJSM0sUigtTlVILFZwDfJWyM7MSwTyMvMyMpMyS_KLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGhuYGFsZmJk5ExMWoAwykvmA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><source>esp@cenet</source><creator>Labesse, Gilles ; Mathieu, Loic ; Bories, Cédric ; Guichou, Jean-François ; Gelin, Muriel ; Geoffroy, Clément ; Bessin, Yannick ; Duquenne, Charline</creator><creatorcontrib>Labesse, Gilles ; Mathieu, Loic ; Bories, Cédric ; Guichou, Jean-François ; Gelin, Muriel ; Geoffroy, Clément ; Bessin, Yannick ; Duquenne, Charline</creatorcontrib><description>The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230725&amp;DB=EPODOC&amp;CC=US&amp;NR=11708364B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230725&amp;DB=EPODOC&amp;CC=US&amp;NR=11708364B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Labesse, Gilles</creatorcontrib><creatorcontrib>Mathieu, Loic</creatorcontrib><creatorcontrib>Bories, Cédric</creatorcontrib><creatorcontrib>Guichou, Jean-François</creatorcontrib><creatorcontrib>Gelin, Muriel</creatorcontrib><creatorcontrib>Geoffroy, Clément</creatorcontrib><creatorcontrib>Bessin, Yannick</creatorcontrib><creatorcontrib>Duquenne, Charline</creatorcontrib><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><description>The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxrErMzEvJz0lVSEktyixLLMksSy1WSMxLUSjJSM0sUigtTlVILFZwDfJWyM7MSwTyMvMyMpMyS_KLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGhuYGFsZmJk5ExMWoAwykvmA</recordid><startdate>20230725</startdate><enddate>20230725</enddate><creator>Labesse, Gilles</creator><creator>Mathieu, Loic</creator><creator>Bories, Cédric</creator><creator>Guichou, Jean-François</creator><creator>Gelin, Muriel</creator><creator>Geoffroy, Clément</creator><creator>Bessin, Yannick</creator><creator>Duquenne, Charline</creator><scope>EVB</scope></search><sort><creationdate>20230725</creationdate><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><author>Labesse, Gilles ; Mathieu, Loic ; Bories, Cédric ; Guichou, Jean-François ; Gelin, Muriel ; Geoffroy, Clément ; Bessin, Yannick ; Duquenne, Charline</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11708364B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Labesse, Gilles</creatorcontrib><creatorcontrib>Mathieu, Loic</creatorcontrib><creatorcontrib>Bories, Cédric</creatorcontrib><creatorcontrib>Guichou, Jean-François</creatorcontrib><creatorcontrib>Gelin, Muriel</creatorcontrib><creatorcontrib>Geoffroy, Clément</creatorcontrib><creatorcontrib>Bessin, Yannick</creatorcontrib><creatorcontrib>Duquenne, Charline</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Labesse, Gilles</au><au>Mathieu, Loic</au><au>Bories, Cédric</au><au>Guichou, Jean-François</au><au>Gelin, Muriel</au><au>Geoffroy, Clément</au><au>Bessin, Yannick</au><au>Duquenne, Charline</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><date>2023-07-25</date><risdate>2023</risdate><abstract>The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US11708364B2
source esp@cenet
subjects ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Azaindole derivatives and their use as ERK kinase inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A20%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Labesse,%20Gilles&rft.date=2023-07-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11708364B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true